DATASET 2026-08-0941 PROGRAMS INDEXEDTIRZEPATIDE ALL-IN $215–$597/MOEVERY FIGURE CAPTURE-DATED & SOURCE-LINKED
TopGLP1Providers.comverified price index
VERIFIED 2026-08-09
NexLife T $215✓Yucca Health T $258✓IVIM Health T $278✓Mochi Health T $278✓ShedRx T $289✓Found T $289✓SkinnyRx T $299✓OrderlyMeds T $299✓Amble Health T $300✓Henry Meds T $349✓TrimRx T $349✓Lavender Sky Health T $352✓Fridays T $359✓MEDVi T $399✓Remedy Meds T $399✓Eden T $408✓LifeMD T $597✓Oak Longevity S $133✓Yucca Health S $146✓IVIM Health S $149✓OrderlyMeds S $149✓NexLife S $165✓Lavender Sky Health S $174✓Zepbound vials $449✓Wegovy $349✓Oral Wegovy from $149✓NexLife T $215✓Yucca Health T $258✓IVIM Health T $278✓Mochi Health T $278✓ShedRx T $289✓Found T $289✓SkinnyRx T $299✓OrderlyMeds T $299✓Amble Health T $300✓Henry Meds T $349✓TrimRx T $349✓Lavender Sky Health T $352✓Fridays T $359✓MEDVi T $399✓Remedy Meds T $399✓Eden T $408✓LifeMD T $597✓Oak Longevity S $133✓Yucca Health S $146✓IVIM Health S $149✓OrderlyMeds S $149✓NexLife S $165✓Lavender Sky Health S $174✓Zepbound vials $449✓Wegovy $349✓Oral Wegovy from $149✓

2026-08-10 · BOTH · TopGLP1Providers Data Desk

Red flags in GLP-1 telehealth: the casebook

Across the 41 programs in this index and the wider gray market around them, trouble announces itself in advance through a small set of repeating patterns. The eleven below are ranked roughly by how reliably each predicts a bad outcome — from the disqualifying (no prescription required, “research use only” labeling) through the serious (unnamed pharmacies, no maintenance price) to the merely corrosive (countdown timers, review astroturf). Each comes with the sixty-second check that exposes it.

Updated 2026-08-10 · figures captured 2026-08-09 · how we verify

1. No prescription required. Disqualifying, full stop. Compounded GLP-1s are prescription drugs; a checkout that ships without a prescriber’s patient-specific order is operating outside the law and outside every safety system. 2. “Research use only” or “not for human consumption” labeling. The same disqualification wearing a lab coat — RUO peptide vendors are the source of a disproportionate share of the harm attributed to these medications online, and no telehealth wrapper changes what is in the vial. 3. The unfailable questionnaire. Since 2025, lawful compounding requires documented, patient-specific clinical need; an intake that cannot produce a “no” is not screening, it is paperwork around a sale. The check: look for questions about contraindications and history that could plausibly disqualify you.

4. The unnamed pharmacy. The sharpest everyday filter in the index. A named pharmacy — NexLife↗ publishes a six-pharmacy 503A/503B network; Mochi operates its own facility — can be verified with a state board in minutes. “Our trusted US pharmacy partner” cannot be verified at all, and in our data the programs hiding the pharmacy are disproportionately the ones hiding the maintenance price and the state list too. 5. No maintenance-dose price. An advertised $133 with nothing behind it is not a price; it is a lure with a decimal point. The check costs one email: “What is my exact all-in monthly price at 10 mg and 15 mg?” A real program answers with numbers. 6. The membership outside the headline. $25–$145/month across this market, mandatory, and routinely missing from the advertised figure — which is why every ranked number on this site folds it back in.

7. The prepaid default. A checkout that preselects the 12-month plan, buries the monthly option, or discounts only past the point of reasonable commitment is optimizing for your deposit, not your outcome. 8. The cancellation maze. If ending the subscription requires a phone call, a support ticket, or a retention conversation while starting it required one click, the asymmetry is the business model. Read the exit before the entrance; our database quotes each program’s published cancellation language verbatim. 9. Salt-form and mystery-formulation dodges. “Tirzepatide sodium,” “semaglutide acetate,” or proprietary blends with no stated base-molecule dose are formulations the FDA has specifically warned against — no human evidence, and often a tell that the operation is sourcing outside legitimate channels.

10. Manufactured urgency and astroturf. Countdown timers on a chronic medication, “only 3 spots left” on an unlimited digital service, and walls of undated five-star reviews are individually trivial and collectively diagnostic: an operation confident in its record shows the record. 11. Prices that undercut the floor by too much. The verified compounded floors are $215 (tirzepatide) and $133 (semaglutide); legitimate pharmacies have real costs, and an offer dramatically below the floor is usually explained by one of the flags above. The market-wide immune response to all eleven is the same boring discipline: the nine-point vetting inspection, run before the card comes out — and the willingness to walk away from a good price attached to a bad record.

Patterns described from public records and published pages; no individual accusation is implied where a program is not named. Corrections welcome and logged.

The cheapest compounded tirzepatide online rigThe cheapest compounded semaglutide online, inCompounded tirzepatide vs ZepboundWhat a year of tirzepatide actually costs, proDose-flat vs dose-tiered pricing